Literature DB >> 28263773

Discovery of specialized pro-resolving mediators marks the dawn of resolution physiology and pharmacology.

Charles N Serhan1.   

Abstract

It is with great pleasure that I write this foreword and introduction to this Special Issue dedicated to the protective actions of the pro-resolving mediators and edited by my colleague Dr. Jesmond Dalli. Many of my collaborators and colleagues that helped to uncover the actions and clinical potential of the resolvins and other specialized proresolving mediators (SPM), namely, the superfamily of pro-resolving mediators that includes the resolvin (E-series, D-series and DPA-derived), protectin and maresin families, as well as the arachidonic acid-derived lipoxins, join me in this special issue. They have given contributions that present exciting new results on the remarkable actions and potency of these unique molecules, the SPM moving forward the importance of their mediators and pathways in human biology. Each contribution to this issue is presented by world authorities in their respective fields covering discoveries that demonstrate the importance and impact of resolution mediators in biology, medicine and surgery. While some of the authors were students and/or fellows with me and others, they are today the founding "resolutionists" of a new era of appreciation of autacoid biosynthesis and metabolomics in human health and disease with their rigorous attention to experimental detail and discovery. The chapters of this issue are filled with exciting new discoveries demonstrating the dynamics and potential of resolution mediators.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Inflammation; Lipoxin; Maresin; Omega-3; Protectin; Resolvin

Mesh:

Substances:

Year:  2017        PMID: 28263773      PMCID: PMC5582020          DOI: 10.1016/j.mam.2017.03.001

Source DB:  PubMed          Journal:  Mol Aspects Med        ISSN: 0098-2997


  163 in total

1.  Alzheimer's Disease: Fatty Acids We Eat may be Linked to a Specific Protection via Low-dose Aspirin.

Authors:  Massimo F L Pomponi; Giovanni Gambassi; Massimiliano Pomponi; Carlo Masullo
Journal:  Aging Dis       Date:  2010-07-12       Impact factor: 6.745

2.  17(R)-Resolvin D1 differentially regulates TLR4-mediated responses of primary human macrophages to purified LPS and live E. coli.

Authors:  Christine D Palmer; Christy J Mancuso; Jerrold P Weiss; Charles N Serhan; Eva C Guinan; Ofer Levy
Journal:  J Leukoc Biol       Date:  2011-06-07       Impact factor: 4.962

Review 3.  Prostaglandin H synthases, nonsteroidal anti-inflammatory drugs, and colon cancer.

Authors:  G N Levy
Journal:  FASEB J       Date:  1997-03       Impact factor: 5.191

4.  Effects of maternal n-3 fatty acid supplementation on placental cytokines, pro-resolving lipid mediators and their precursors.

Authors:  Jeffrey A Keelan; Emilie Mas; Nina D'Vaz; Janet A Dunstan; Shaofu Li; Anne E Barden; Peter J Mark; Brendan J Waddell; Susan L Prescott; Trevor A Mori
Journal:  Reproduction       Date:  2014-12-12       Impact factor: 3.906

Review 5.  Systems approach to inflammation resolution: identification of novel anti-inflammatory and pro-resolving mediators.

Authors:  C N Serhan
Journal:  J Thromb Haemost       Date:  2009-07       Impact factor: 5.824

6.  Resolvin E1 promotes phagocytosis-induced neutrophil apoptosis and accelerates resolution of pulmonary inflammation.

Authors:  Driss El Kebir; Per Gjorstrup; János G Filep
Journal:  Proc Natl Acad Sci U S A       Date:  2012-08-27       Impact factor: 11.205

7.  Aging delays resolution of acute inflammation in mice: reprogramming the host response with novel nano-proresolving medicines.

Authors:  Hildur H Arnardottir; Jesmond Dalli; Romain A Colas; Masakazu Shinohara; Charles N Serhan
Journal:  J Immunol       Date:  2014-09-12       Impact factor: 5.422

Review 8.  Pro-resolving lipid mediators are leads for resolution physiology.

Authors:  Charles N Serhan
Journal:  Nature       Date:  2014-06-05       Impact factor: 49.962

9.  Involvement of pigment epithelium-derived factor, docosahexaenoic acid and neuroprotectin D1 in corneal inflammation and nerve integrity after refractive surgery.

Authors:  S Kenchegowda; J He; H E P Bazan
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2012-05-10       Impact factor: 4.006

10.  Emerging roles of eosinophils and eosinophil-derived lipid mediators in the resolution of inflammation.

Authors:  Yosuke Isobe; Taiga Kato; Makoto Arita
Journal:  Front Immunol       Date:  2012-08-28       Impact factor: 7.561

View more
  67 in total

1.  Developments of specialized pro-resolving mediators in periodontitis.

Authors:  Yin-Chen Liu
Journal:  Hua Xi Kou Qiang Yi Xue Za Zhi       Date:  2021-02-01

Review 2.  Specialized Pro-Resolving Lipid Mediators: Emerging Therapeutic Candidates for Multiple Sclerosis.

Authors:  Insha Zahoor; Shailendra Giri
Journal:  Clin Rev Allergy Immunol       Date:  2021-04       Impact factor: 8.667

3.  Relationship of Omega-3 fatty acids DHA and EPA with the inflammatory biomarker hs-CRP in children with sickle cell anemia.

Authors:  B N Yamaja Setty; Suhita Gayen Betal; Robin E Miller; Dawn S Brown; Maureen Meier; Michele Cahill; Norma B Lerner; Nataly Apollonsky; Marie J Stuart
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2019-05-10       Impact factor: 4.006

Review 4.  Specialized pro-resolving mediator network: an update on production and actions.

Authors:  Nan Chiang; Charles N Serhan
Journal:  Essays Biochem       Date:  2020-09-23       Impact factor: 8.000

5.  Are specialized pro-resolving mediators promising therapeutic agents for severe bronchial asthma?

Authors:  Takeshi Hisada; Haruka Aoki-Saito; Yasuhiko Koga
Journal:  J Thorac Dis       Date:  2017-11       Impact factor: 2.895

6.  Identification and Complete Stereochemical Assignments of the New Resolvin Conjugates in Tissue Regeneration in Human Tissues that Stimulate Proresolving Phagocyte Functions and Tissue Regeneration.

Authors:  Xavier de la Rosa; Paul C Norris; Nan Chiang; Ana R Rodriguez; Bernd W Spur; Charles N Serhan
Journal:  Am J Pathol       Date:  2018-04       Impact factor: 4.307

7.  Resolvin the clot: DVT resolution through RvD4.

Authors:  Michael Holinstat
Journal:  Blood       Date:  2019-10-24       Impact factor: 22.113

Review 8.  Redox (phospho)lipidomics of signaling in inflammation and programmed cell death.

Authors:  Yulia Y Tyurina; Claudette M St Croix; Simon C Watkins; Alan M Watson; Michael W Epperly; Tamil S Anthonymuthu; Elena R Kisin; Irina I Vlasova; Olga Krysko; Dmitri V Krysko; Alexandr A Kapralov; Haider H Dar; Vladimir A Tyurin; Andrew A Amoscato; Elena N Popova; Sergey B Bolevich; Peter S Timashev; John A Kellum; Sally E Wenzel; Rama K Mallampalli; Joel S Greenberger; Hulya Bayir; Anna A Shvedova; Valerian E Kagan
Journal:  J Leukoc Biol       Date:  2019-05-09       Impact factor: 4.962

Review 9.  Can Specialized Pro-resolving Mediators Deliver Benefit Originally Expected from Fish Oil?

Authors:  Martin D Rosenthal; Jayshil Patel; Kyle Staton; Robert G Martindale; Frederick A Moore; Gilbert R Upchurch
Journal:  Curr Gastroenterol Rep       Date:  2018-08-04

10.  Inhibition of Δ24-dehydrocholesterol reductase activates pro-resolving lipid mediator biosynthesis and inflammation resolution.

Authors:  Andreas Körner; Enchen Zhou; Christoph Müller; Yassene Mohammed; Sandra Herceg; Franz Bracher; Patrick C N Rensen; Yanan Wang; Valbona Mirakaj; Martin Giera
Journal:  Proc Natl Acad Sci U S A       Date:  2019-09-23       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.